Nippon Gases has signed a deal to acquire respiratory home therapies specialist Esteve Teijin Healthcare (ETH).
ETH is a joint venture between Corporación Quimico-Farmacéutica Esteve (CQFE) and Teijin Holdings Europe BV (Teijin) that was set up in 2009.
The business aligns with Nippon Gases’ existing business model, combining ETH’s knowledge in respiratory therapies with Nippon Gases’ field expertise.
Justin Corcho, CEO of Nippon Gases España, described the news as an historic combination, culturally and strategically, within the Spanish homecare market.
